Short answer
CG Oncology, Inc. (CGON) filed an 8-K current report with the SEC on May 8, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 financial results for quarter ended March 31, 2026.
CG Oncology, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 financial results for quarter ended March 31, 2026
- Press release available as Exhibit 99.1 for detailed results and management commentary
- Disclosure furnished under Form 8-K Item 2.02 and not deemed filed under Exchange Act Section 18 liability rules
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CG Oncology, Inc. 8-K filings
Get the next CGON 8-K as it lands
Follow CGON for push alerts, or ask the research agent what this filing means.